Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis

Purpose: Calcitonin gene-related peptide monoclonal antibodies (CGRPmAbs) are new agents approved by the US Food and Drug Administration for preventive treatment of chronic migraine. Comparison between CGRPmAbs and previously approved Botulinum neurotoxin A (BoNT-A) will inform optimal preventive tr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Chen, Yao-Yao, Ye, Xiao-Qian, Tang, Tai-Chun, She, Tian-Wei, Chen, Min, Zheng, Hui
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8170150/
https://ncbi.nlm.nih.gov/pubmed/34093199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.671845
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki